Renaissance of glucocorticoids in critical care in the era of COVID-19: ten urging questions
Abstract The 40-year-old experience with glucocorticosteroids (GCs) in the context of severe infections is complex and troublesome. Recently, however, a clear indication for GCs in severe COVID-19 has been established. This may constitute a harbinger of a wider use of GCs in critical illnesses. A fu...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2022-10-01
|
| Series: | Critical Care |
| Online Access: | https://doi.org/10.1186/s13054-022-04185-9 |